Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE
ChiCTR-OPN-16008859Phase 4Not yet recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone in cancer pain, sponsored by Zhejiang Cancer Hospital. Primary endpoint: Pain remission at day 3. Planned start Aug 2016; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR-OPN-16008859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16008859.